SRAM
TAK icon

Spouting Rock Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Spouting Rock Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-65,522
Closed -$1.17M – 194
2020
Q3 		$1.17M Sell
65,522
-59,282
-48% -$1.08M 0.56% 59
2020
Q2 		$2.24M Hold
124,804
– – 1.06% 16
2020
Q1 		$1.9M Sell
124,804
-41,602
-25% -$754K 1.31% 16
2019
Q4 		$3.28M Buy
+166,406
New +$3.18M 0.84% 26

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM

Spouting Rock Asset Management's TAK Position: Q4 2020 in Review

Spouting Rock Asset Management sold out of Takeda Pharmaceutical (TAK) in Q4 2020, closing a stake of 65,522 shares — an estimated $1.17M sold.

Spouting Rock Asset Management first reported a position in TAK in Q4 2019 and held it in 4 quarters. The position peaked at $3.28M in Q4 2019. 313 funds tracked by Wall St. Rank hold TAK as of Q4 2020.

  • Spouting Rock Asset Management reported no remaining Takeda Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Spouting Rock Asset Management sold 65,522 Takeda Pharmaceutical shares in Q4 2020, an estimated $1.17M.
  • Spouting Rock Asset Management first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 4 quarters.
  • Spouting Rock Asset Management's Takeda Pharmaceutical position peaked at $3.28M in Q4 2019.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2020.

Based on Spouting Rock Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.